MART-1 (26-35) (human) CAS NO.156251-01-3

<p>MART-1 (26-35) (human) is a synthetic decapeptide corresponding to residues 26-35 of the human melanoma antigen recognized by T-cells (MART-1). With CAS NO. 156251-01-3, it is a high-purity, well-defined research tool primarily used in immunology and oncology to study T-cell mediated immune responses against melanoma and other cancers.</p>

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com

View on supplier website More from this supplier

Source categories

Peptides

About this product

Product information from the supplier.

TECHNICAL SPECIFICATIONS

Item	Specification
Product Name	MART-1 (26-35) (human)
CAS NO.	156251-01-3
Appearance	White to off-white lyophilized powder
Molecular Formula	C42H74N10O14
Molecular Weight	943.12g/mol
Purity (RP-HPLC)	≥ 95.0%
Solubility	Soluble in water, 0.1 M acetic acid, or DMSO at a concentration ≥ 1 mg/mL.
Endotoxin	< 1.0 EU/mg
Biological Activity	Recognized by HLA-A2-restricted cytotoxic T lymphocytes (CTLs) specific to MART-1.
Storage Conditions	Store long-term at -20°C to -80°C; avoid repeated freeze-thaw cycles.
Stock Location	Stock in USA
MOQ	1g

1.MECHANISM OF ACTION

This peptide is a native HLA-A*02:01-restricted epitope derived from the melanocyte differentiation antigen MART-1/Melan-A. When presented by antigen-presenting cells (APCs), it effectively activates antigen-specific cytotoxic T-lymphocytes (CTLs). These activated CTLs then recognize and eliminate tumor cells expressing the endogenous MART-1 protein, providing a specific target for adaptive anticancer immunity.

2.PRODUCT INDICATIONS

This peptide is indicated for use in scientific research applications, including: in vitro T-cell stimulation and expansion, immune monitoring assays, development and evaluation of peptide-based cancer vaccines, assessment of adoptive T-cell therapy efficacy, and as a critical reagent for studying antigen-specific immune responses in melanoma and vitiligo research.

3.CLINICAL EFFICACY OF PRODUCT

As a research-grade reagent, MART-1 (26-35) is a cornerstone antigen in numerous clinical investigations. Studies have demonstrated its ability to consistently induce robust MART-1-specific T-cell responses in vitro and in vivo. It has been widely used in clinical trials for melanoma vaccines and adoptive T-cell transfer therapies, showing safety and immunogenicity, though therapeutic efficacy can vary based on the treatment modality and patient factors.

4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.